KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E Adjustments
Ratios

TherapeuticsMD (TXMD) Long-Term Debt Repayments: 2011-2022

Historic Long-Term Debt Repayments for TherapeuticsMD (TXMD) over the last 2 years, with Dec 2022 value amounting to $94.4 million.

  • TherapeuticsMD's Long-Term Debt Repayments was N/A to $94.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was $269.4 million, marking a year-over-year change of. This contributed to the annual value of $219.4 million for FY2022, which is 338.86% up from last year.
  • TherapeuticsMD's Long-Term Debt Repayments amounted to $94.4 million in Q4 2022, which was down 21.31% from $120.0 million recorded in Q2 2022.
  • Over the past 5 years, TherapeuticsMD's Long-Term Debt Repayments peaked at $120.0 million during Q2 2022, and registered a low of $5.0 million during Q1 2022.
  • Its 2-year average for Long-Term Debt Repayments is $67.4 million, with a median of $72.2 million in 2021.
  • Data for TherapeuticsMD's Long-Term Debt Repayments shows a maximum YoY crashed of 90.00% (in 2022) over the last 5 years.
  • Quarterly analysis of 2 years shows TherapeuticsMD's Long-Term Debt Repayments stood at $50.0 million in 2021, then crashed by 90.00% to $94.4 million in 2022.
  • Its last three reported values are $94.4 million in Q4 2022, $120.0 million for Q2 2022, and $5.0 million during Q1 2022.